| VMware: “We Bought Carbon Black for $2.1B!” Analysts: “Oh… Why?” | Brian Dowling | 08/23/19 | Boston |
| Dell Sets Return to Public Market With Shareholder OK of VMware Deal | David Holley | 12/11/18 | Texas |
| Dell Reportedly Mulling a VMware Reverse Merger: What Could It Mean? | David Holley | 01/29/18 | Texas |
| Exact Sciences Raises $174M, Nearly Doubles War Chest For Diagnostics | Jeff Bauter Engel | 07/23/15 | Wisconsin |
| As Rival Sputters, FibroGen Heads to Nasdaq Via $146M IPO | Ben Fidler | 11/14/14 | San Francisco |
| Connecture, WI Health Insurance Software Company, Plans $86M IPO | Jeff Bauter Engel | 10/21/14 | Wisconsin |
| Tokai Bags $97M For Prostate Cancer Drug in Upsized IPO | Ben Fidler | 09/17/14 | Boston |
| Tokai, Chasing the Field in Prostate Cancer, Files For IPO | Ben Fidler | 08/12/14 | Boston |
| Avalanche Bio Rolls Onto Nasdaq After Upsized, $102M IPO | Ben Fidler | 07/31/14 | San Francisco |
| Who Are Biotech’s New Go-To Investment Bankers? | Luke Timmerman | 11/12/12 | National |
| OncoGenex Stays in Prostate Cancer Fray, After J&J, Medivation | Luke Timmerman | 01/27/12 | Seattle |
| No Surgical Sponge Left Behind: RF Surgical Seeks to Lead Market for High-Tech Gauze | Luke Timmerman | 11/03/10 | Seattle |
